Comments
Vivimed Labs’ API manufacturing facility at Cuernavaca, Mexico, was recently inspected by the USFDA in compliance with their requirements. The inspection was successful, and the company obtained the Establishment Inspection Report. Shares of Vivemed Labs edged down 1.42 per cent at ₹38.30 on the NSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.